Differential somatostatin and CXCR4 chemokine receptor expression in MALT-type lymphoma of gastric and extragastric origin
- 20 August 2016
- journal article
- research article
- Published by Springer Nature in Journal of Cancer Research and Clinical Oncology
- Vol. 142 (11) , 2239-2247
Abstract
Purpose Whereas the different somatostatin receptor (SSTR) subtypes and the chemokine receptor CXCR4 are known to be expressed in a wide variety of human malignancies, comprehensive data are still lacking for MALT-type lymphomas. Methods Overall, 55 cases of MALT-type lymphoma of both gastric and extragastric origin were evaluated for the SSTR subtype and CXCR4 expression by means of immunohistochemistry using novel monoclonal rabbit antibodies. The stainings were rated by means of the immunoreactive score and correlated with clinical data. Results While the CXCR4 was detected in 92 % of the cases investigated, the SSTR subtypes were much less frequently present. The SSTR5 was expressed in about 50 % of the cases, followed by the SSTR3, the SSTR2A, the SSTR4 and the SSTR1, which were present in 35, 27, 18 or 2 %, respectively, of the tumors only. Gastric lymphomas displayed a significantly higher SSTR3, SSTR4 and SSTR5 expression than extragastric tumors. A correlation between CXCR4 and Ki-67 expression was seen in gastric lymphomas, whereas primarily in extragastric tumors SSTR5 negativity was associated with poor patient outcome. Conclusions The CXCR4 may serve as a promising target for diagnostics and therapy of MALT-type lymphomas, while the SSTRs appear not suitable in this respect.Keywords
This publication has 48 references indexed in Scilit:
- Disclosing the CXCR4 Expression in Lymphoproliferative Diseases by Targeted Molecular ImagingTheranostics, 2015
- CXCR4 expression enhances diffuse large B cell lymphoma dissemination and decreases patient survivalThe Journal of Pathology, 2014
- Targeting the CD20 and CXCR4 Pathways in Non-Hodgkin Lymphoma with Rituximab and High-Affinity CXCR4 Antagonist BKT140Clinical Cancer Research, 2013
- Reevaluation of sst1 somatostatin receptor expression in human normal and neoplastic tissues using the novel rabbit monoclonal antibody UMB-7Regulatory Peptides, 2013
- Radiotherapy in marginal zone lymphomaRadiation Oncology, 2013
- Non-Hodgkin's Lymphoma of Mucosa-Associated Lymphoid TissueThe Oncologist, 2006
- High Relapse Rate in Patients with MALT Lymphoma Warrants Lifelong Follow-upClinical Cancer Research, 2005
- Somatostatin Receptor Scintigraphy in MALT Lymphoma of the Lacrimal Gland Treated with RituximabLeukemia & Lymphoma, 2004
- The significance of cancer cell expression of the chemokine receptor CXCR4Seminars in Cancer Biology, 2004
- Chemokine receptors that mediate B cell homing to secondary lymphoid tissues are highly expressed in B cell chronic lymphocytic leukemia and non-Hodgkin lymphomas with widespread nodular disseminationJournal of Leukocyte Biology, 2004